Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early follicular-phase rLH supplementation in poor ovarian response ART
ChiCTR2100052658Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of lutropin alfa in infertility and poor ovarian response (POR) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Number of available eggs and Number of available embryos. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
lutropin alfa
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR2100052658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052658.